Analysis of direct medical costs in the inpatient treatment of sepsis at Thong Nhat Dong Nai General Hospital in 2024
Các tác giả
DOI: https://doi.org/10.59294/HIUJS20250119Từ khóa:
direct medical cost, sepsis, multivariable regressionTóm tắt
Background: Sepsis is a severe, life-threatening condition that imposes a substantial economic burden on both patients and the healthcare system. At Thong Nhat Dong Nai General Hospital, no prior study has evaluated the direct medical costs (DMCs) associated with inpatient treatment of sepsis. Objectives: To analyze the DMCs and identify factors associated with the inpatient treatment among sepsis patients at Thong Nhat Dong Nai General Hospital, in 2024. Methods: A cross-sectional descriptive study was conducted using a retrospective review of electronic billing data from sepsis inpatients who met the inclusion criteria at Thong Nhat Dong Nai General Hospital in 2024. Results: A total of 1,270 treatment episodes were analyzed. The mean patient age was 62.76 ± 16.91 years, with an average hospital stay of 11.91 ± 8.20 days. Most patients (95%) received broad-spectrum antibiotics. The mean DMC per inpatient sepsis episode was 13,440,089 VND (95% CI: 12,332,970 - 14,547,219 VND). Drug costs accounted for the largest proportion (41.51%) of total expenses, and health insurance covered 86.57% of total DMCs. The multivariable regression model demonstrated significant associations between log-transformed DMCs (adjusted R² = 0.661; p < 0.05) and the following predictors: Log(DMC) = 0.656 × “Length of stay” + 0.166 × “ICU admission” + 0.126 × “Other interventions” + 0.100 × “COPD/chronic lung disease” + 0.096 × “Chronic liver disease” + 0.079 × “Mortality” + 0.070 × “Diabetes mellitus” + 0.070 × “Broad-spectrum antibiotic use” + 0.062 × “Age” + 0.047 × “Chronic kidney disease” + 0.042 × “Surgery” + 6.159. Conclusions: The mean DMC per sepsis hospitalization was substantial, approximately one-fifth of Vietnam's estimated average per capita income in 2024. Drug costs represented the largest proportion of expenditures, while health insurance covered the majority of expenses. The multivariable regression identified eleven significant factors associated with DMCs (adjusted R² = 0.661).
Abstract
Background: Sepsis is a severe, life-threatening condition that imposes a substantial economic burden on both patients and the healthcare system. At Thong Nhat Dong Nai General Hospital, no prior study has evaluated the direct medical costs (DMCs) associated with inpatient treatment of sepsis. Objectives: To analyze the DMCs and identify factors associated with the inpatient treatment among sepsis patients at Thong Nhat Dong Nai General Hospital, in 2024. Methods: A cross-sectional descriptive study was conducted using a retrospective review of electronic billing data from sepsis inpatients who met the inclusion criteria at Thong Nhat Dong Nai General Hospital in 2024. Results: A total of 1,270 treatment episodes were analyzed. The mean patient age was 62.76 ± 16.91 years, with an average hospital stay of 11.91 ± 8.20 days. Most patients (95%) received broad-spectrum antibiotics. The mean DMC per inpatient sepsis episode was 13,440,089 VND (95% CI: 12,332,970 - 14,547,219 VND). Drug costs accounted for the largest proportion (41.51%) of total expenses, and health insurance covered 86.57% of total DMCs. The multivariable regression model demonstrated significant associations between log-transformed DMCs (adjusted R² = 0.661; p < 0.05) and the following predictors: Log(DMC) = 0.656 × “Length of stay” + 0.166 × “ICU admission” + 0.126 × “Other interventions” + 0.100 × “COPD/chronic lung disease” + 0.096 × “Chronic liver disease” + 0.079 × “Mortality” + 0.070 × “Diabetes mellitus” + 0.070 × “Broad-spectrum antibiotic use” + 0.062 × “Age” + 0.047 × “Chronic kidney disease” + 0.042 × “Surgery” + 6.159. Conclusions: The mean DMC per sepsis hospitalization was substantial, approximately one-fifth of Vietnam's estimated average per capita income in 2024. Drug costs represented the largest proportion of expenditures, while health insurance covered the majority of expenses. The multivariable regression identified eleven significant factors associated with DMCs (adjusted R² = 0.661).
Tài liệu tham khảo
[1] M. Singer et al., "The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)," JAMA, vol. 315, no. 8, pp. 801-810, 2016.
[2] L. Evans et al., "Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021," Crit. Care Med., vol. 49, no. 11, pp. e1063-e1143, 2021.
[3] K. E. Rudd et al., "Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study," Lancet, vol. 395, no. 10219, pp. 200-211, 2020.
[4] R. M. Riu, P. Chiarello, R. Terradas, et al., "Cost attributable to nosocomial bacteremia: Analysis according to microorganism and antimicrobial sensitivity in a university hospital in Barcelona," PLOS ONE, vol. 11, no. 4, p. e0153076, 2016.
[5] B. T. H. Giang, D. D. Thanh, and N. T. Anh, "Một số yếu tố tiên lượng tử vong tại ngày thứ 28 trên bệnh nhân sốc nhiễm khuẩn," Tạp chí Y học Việt Nam, vol. 535, no. 1, 2024. [Online]. Available: https://doi.org/10.51298/vmj.v535i1.8356.
[6] N. T. Huyền and T. T. D. Ngân, "Giá trị tiên lượng tử vong của lactat máu ở người bệnh sốc nhiễm khuẩn điều trị tại Bệnh viện Bệnh Nhiệt đới Trung ương giai đoạn 2018-2022," Tạp chí Y học Việt Nam, vol. 522, no. 2, 2023. [Online]. Available: https://doi.org/10.51298/vmj.v522i2.4341.
[7] B. Cheng, Z. Li, J. Wang et al., "Comparison of the performance of Sepsis-2 and Sepsis-3 in a Chinese ICU," Medicine (Baltimore), vol. 99, no. 17, p. e19834, 2020.
[8] C. J. Paoli, M. A. Reynolds, M. Sinha et al., "Epidemiology and Costs of Sepsis in the United States - An Analysis Based on Timing of Diagnosis and Severity Level," Crit. Care Med., vol. 46, no. 12, pp. 1889-1897, 2018.
[9] B. M. Hạnh, K. Q. Long, L. P. Anh et al., "Cost of postoperative sepsis in Vietnam," Sci. Rep., vol. 12, no. 1, p. 4876, 2022, https://doi.org/10.1038
/s41598-022-08881-y.
[10] Tổng cục Thống kê, Thông cáo báo chí: Kết quả Khảo sát mức sống dân cư năm 2024, Hà Nội: Tổng cục Thống kê, 2024. [Online]. Available: https://www.nso.gov.vn/tin-tuc-thong-ke/2025/05/thong-cao-bao-chi-ket-qua-khao-sat-muc-song-dan-cu-nam-2024.
[11] N. V. Tuấn, Mô hình hồi quy và khám phá khoa học. Thành phố Hồ Chí Minh, Việt Nam: Nhà xuất bản Tổng hợp, 2020, pp. 157-172.
[12] N. V. Phương, N. P. Nam, V. N. Hậu…, N. V. Tình, “Tình trạng giảm tiểu cầu và một số chỉ số liên quan tiểu cầu trên người bệnh nhiễm khuẩn huyết”, VMJ, vol 552, số p.h 1, tháng 7 2025.
[13]L. T. T. Duyên, B. V. Mạnh, và P. T. Dũng, “Nghiên cứu một số đặc điểm lâm sàng, cận lâm sàng của bệnh nhân nhiễm khuẩn huyết do vi khuẩn gram âm tại bệnh viện hữu nghị việt tiệp giai đoạn 2018 - 2020”, VMJ, vol 528, số p.h 2, tháng 8 2023.
[14] T. Q. Đúng, V. M. Phương, và N. H. Hà, “Tình hình đề kháng kháng sinh và đánh giá việc quản lý sử dụng kháng sinh ở bệnh nhân nhiễm khuẩn huyết tại bệnh viện đa khoa Cà Mau”, VMJ, vol 530, số p.h 1B, tháng 9 2023.
[15] N. T. Luân và N. T. Dũng, “Tỷ lệ tử vong ở bệnh nhân sốc nhiễm khuẩn tại việt nam giai đoạn 2020 - 2024: một tổng quan tường thuật”, VMJ, vol 554, số p.h 3, tháng 10 2025.
[16] M. van den Berg, F. E. van Beuningen, J. C. ter Maaten, and H. R. Bouma, “Hospital-related costs of sepsis around the world: A systematic review exploring the economic burden of sepsis,” Journal of Critical Care, vol. 71, p. 154096, 2022. [Online]. Available: https://doi.org/10.1016
/j.jcrc.2022.154096.
[17] N. T. T. Thủy, “Phân tích chi phí trực tiếp y tế trong điều trị nhiễm nấm xâm,” Tạp chí Dược - Tạp chí Y học TP HCM, vol. 28, no. 6, pp. 43-51, 2025. [Online]. Available: https://www.duoc.tapchi
yhoctphcm.vn/upload/2025/28(6)2025/D-05-NC%2028(6)2025%2043-51-Nguyen%20Thi
%20Thu%20Thuy.pdf.
Tải xuống
Tải xuống: 0




